ChemToTech

CAS No. 368870-50-2

2-Furancarboxamide,N-(7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-

2-Furancarboxamide,N-(7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-

368870-50-2
  • Catalog No.: 1706576
  • Name: 2-Furancarboxamide,N-(7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-
  • CAS: 368870-50-2
  • Formula: C20H14ClN3O3

Filed under: Benzodiazepin, Benzo, Carboxamide

Inquire about this product → | Safety data

About 2-Furancarboxamide,N-(7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-

2-Furancarboxamide,N-(7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)- is a chemical compound registered under CAS number 368870-50-2, with the molecular formula C20H14ClN3O3 and a molecular weight of about 379.8 g/mol. ChemToTech supplies 2-Furancarboxamide,N-(7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)- for laboratory research and bulk production; product code 1706576. Send an inquiry for purity, packaging, price and lead time.

CAS Number
368870-50-2
Molecular Formula
C20H14ClN3O3
Molecular Weight
379.8 g/mol
Related Keywords
benzodiazepin
furancarboxamide
  • 1,4-BIS(3,4,5-TRIMETHOXYPHENYL)TETRAHYDRO-1H,3H-FURO[3,4-C]FURAN
  • 1,3-Dioxolane, 4-ethyl-5-octyl-2,2-bis(trifluoromethyl)-, trans-
  • 1,8-Naphthyridine-3-carboxylic acid,7-(1S,4S)-2,5-diazabicyclo[2.2.1]hept-2-yl-6-fluoro-1,4-dihydro-4-oxo-1-(3-phenyl-2-propynyl)-, ethyl ester
  • 1,8-Naphthyridine-3-carboxylic acid, 2-[2-(4-chlorobenzoyl)hydrazino]-,ethyl ester
  • 1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-methyl-4-oxo-,2-[(phenylamino)thioxomethyl]hydrazide
  • 1,3-Dioxolane, 4-[1,3-bis(4-methoxyphenyl)-1-propenyl]-2,2-dimethyl-
    68940-88-5
  • Phenylalanine,4-[[(3,5-dichloro-4-pyridinyl)carbonyl]amino]-N-6-quinolinyl-
  • 1,3-Dioxolane, 4-ethenyl-5-(2-furanyl)-2,2-dimethyl-, (4R,5R)-rel-
  • 1,8-Naphthyridine-3-carboxylic acid,7-[[3-[(3-aminopropyl)methylamino]propyl]amino]-6-fluoro-1,4-dihydro-5-methyl-4-oxo-
  • 1,3-Dioxolane,2-(1-methylethyl)-4-[(4-phenoxyphenoxy)methyl]-2-propyl-
  • 1,8-Naphthyridine-3-carboxylic acid,1-(2-cyanoethyl)-7-[3-[[(1,1-dimethylethoxy)carbonyl]amino]-1-azetidinyl]-6-fluoro-1,4-dihydro-4-oxo-
  • 1,8-Naphthyridine-3-carboxylic acid,7-[3-(aminomethyl)-1-pyrrolidinyl]-6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-
    105573-16-8
  • 1,5-Benzoxazepin-4-amine,3-[(3-chlorophenyl)azo]-2,3-dihydro-N,N,2-triphenyl-
  • 1,8-Naphthyridine-3-carboxylic acid,1-ethyl-1,4-dihydro-7-methyl-4-oxo-, nickel(2+) salt
  • 5-Hepten-2-one, 5-methyl-7-(trimethylsilyl)-, (E)-
  • 1,5-Benzothiazepine, 4-(1H-benzimidazol-2-yl)-2,3-dihydro-2-phenyl-
  • 1,5-Benzothiazepine,4-(1H-benzimidazol-2-yl)-2,3-dihydro-2-(4-nitrophenyl)-
  • PKR Inhibitor, Negative Control
    852547-30-9
  • 1,8-Naphthyridine-3-carboxamide,N-cyclopropyl-1,4-dihydro-1-[3-[(1-oxido-3-pyridinyl)ethynyl]phenyl]-4-oxo-
  • 1,8-Naphthyridine-3-carboxylic acid,7-[3-[(2,3-dihydroxypropyl)amino]-1-pyrrolidinyl]-1,4-dihydro-5-methyl-4-oxo-
  • 4-Morpholinecarboxylic acid,5-[(1S,2S)-2-(acetylamino)-3-(3,5-difluorophenyl)-1-hydroxypropyl]-2-(2-methylpropoxy)-, 1,1-dimethylethyl ester, (2S,5R)-
  • 1,3-Dioxolane, 4-phenyl-2-propyl-
  • 3'-(2-CARBOXYBENZAMIDO)BENZANILDE-2-CARBOXYLIC ACID, 97%
  • [1,2,4]Triazolo[1,5-a]pyridine-5-carboxamide,N-ethyl-2-[[(ethylamino)carbonyl]amino]-7-(2-fluorophenyl)-
    882520-64-1
  • 1,3-Dioxolane,2-(2-bromophenyl)-2-[[(1R,2S)-2-nitrocyclohexyl]methyl]-, rel-
  • 1,8-Naphthyridine-3-carboxylic acid,7-(3-amino-1-pyrrolidinyl)-6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-, hydrochloride
  • 1-[2-(diethylamino)ethylamino]-7-hydroxy-4-methylthioxanthen-9-one;hydroiodide
  • 3-(n'-phenylcarbamimidoyl)sulfanylpropyl N'-phenylcarbamimidothioate;dihydrobromide
  • 1,8-Naphthyridine-3-carboxylic acid,7-(1-azetidinyl)-1,4-dihydro-4-oxo-6-(1-propynyl)-
  • Phosphine oxide, [(1E)-2-cyclohexyl-1-methylethenyl]diphenyl-
    372167-06-1
  • 1,3-Dioxolane, 4-methyl-2-(3,4,5-trimethoxyphenyl)-
  • Eucalyptus Citriodora Oil 75%
  • 1,3-Dioxolane, 2-methoxy-2-methyl-4-(phenoxymethyl)-
  • 1,8-Naphthyridine-3-carboxylic acid,7-[3-(acetylamino)-4-methyl-1-pyrrolidinyl]-6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-, ethyl ester
  • 1,5-Benzothiazepinium, 2,3-dihydro-2,2,4,5-tetramethyl-, perchlorate
  • 1,3-Dioxolane, 5-ethenyl-2,2,4-trimethyl-4-(2-naphthalenyl)-,(4R,5S)-rel-
    558483-73-1